![Sartorius Stedim Biotech S.A. Website](https://cdn.finchat.io/43246930.png)
Sartorius Stedim Biotech S.A.
ENXTPA-DIM
Company Overview
Sartorius Stedim Biotech S.A. produces and sells instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, filtration, purification, and fluid management services; single-use and reusable hollow-fiber membrane devices, as well as presterilized assemblies for cell and gene therapy applications; and cell harvesting and various other solutions for intensified bioprocesses. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production. It serves manufacturers of pharmaceuticals, foods, and chemicals, as well as research and development laboratories. The company was founded in 1870 and is headquartered in Aubagne, France. Sartorius Stedim Biotech S.A. is a subsidiary of Sartorius AG.
Name
Sartorius Stedim Biotech S.A.
CEO
Dr. Rene Faber
Website
www.sartorius.com
Sector
Life Sciences Tools and Services
Year Founded
1978
Profile
Market Cap
€17.39B
EV
€19.89B
Shares Out
97.31M
Revenue
€2,746.9M
Employees
10,382
Margins
Gross
43.16%
EBITDA
23.73%
Operating
15.18%
Pre-Tax
8.61%
Net
6.17%
FCF
11.1%
Returns (5Yr Avg)
ROA
12.85%
ROTA
37.58%
ROE
24.82%
ROCE
25.23%
ROIC
16.91%
Valuation (TTM)
P/E
—
P/B
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
EV/Gross Profit
—
Valuation (NTM)
Price Target
€211.79
P/E
—
PEG
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
Financial Health
Cash
€454.1M
Net Debt
€2,464.9M
Debt/Equity
0.74
EBIT/Interest
2.47
Growth (CAGR)
Rev 3Yr
4.71%
Rev 5Yr
15.51%
Rev 10Yr
16.05%
Dil EPS 3Yr
-29.3%
Dil EPS 5Yr
-6.94%
Dil EPS 10Yr
9.49%
Rev Fwd 2Yr
4.52%
EBITDA Fwd 2Yr
7.94%
EPS Fwd 2Yr
4.95%
EPS LT Growth Est
21.15%
Dividends
Yield
—
Payout
38.36%
DPS
€0.69
DPS Growth 3Yr
0.49%
DPS Growth 5Yr
3.9%
DPS Growth 10Yr
13.18%
DPS Growth Fwd 2Yr
3.37%